| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |